Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT04915365

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04915365
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Kyrgyzstan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04915365. Randomized; no masking; primary purpose prevention. Start 2021-05-01 (actual); primary completion 2022-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude
Condition
Right Heart Function
Condition
Chronic Obstructive Pulmonary Disease
Condition
Altitude Sickness
Intervention (Drug)
Acetazolamide
Intervention (Drug)
Placebo
Lead sponsor
University of Zurich (class: other)
Collaborator
National Center of Cardiology and Internal Medicine, Kyrgyz Republic (class: not stated)

Record details

Record id
cardio:ct-nct04915365
Content hash
e640f7acf5d92c3672525bc04ae949d99c05f760755c4812d658bc8d3d837aec